Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

iAnthus Capital Holdings Inc. ITHUF


Primary Symbol: C.IAN

iAnthus Capital Holdings, Inc. is a vertically integrated, multi-state owner and operator of licensed cannabis cultivation, processing, and dispensary facilities. The Company is also a developer, producer, and distributor of branded cannabis and cannabidiol (CBD) products in the United States. Through its subsidiaries, the Company owns and/or operates 37 dispensaries and eight cultivation and/or processing facilities in seven United States. Its multi-state operations encompass a full range of medical and adult-use cannabis enterprises, including cultivation, processing, product development, wholesale-distribution, and retail. The Company offers various cannabis products, which includes flower and trim, products containing cannabis flower and trim, such as packaged flower and pre-rolls; cannabis infused products, such as topical creams and edibles and products containing cannabis extracts, such as vape cartridges, concentrates, live resins, wax products, oils, and tinctures.


CSE:IAN - Post by User

Post by TeamEddieon Jun 03, 2020 9:26pm
152 Views
Post# 31109509

upgrade

upgrade

 In the wake of the release of in-line third-quarter results, Paradigm Capital analyst J. Marvin Wolff raised his target for NanoXplore Inc. (GRA-X) to $4.85 from $3.85 with a “buy” rating (unchanged). The average on the Street is $3.07.

“With the graphene plant set to start commercial production soon and supply contracts under negotiation, we are maintaining our target EV/EBITDA multiple of 17.5 times using 2023 (a full year of 10,000-tpa graphene production), EBITDA of $48.5-million and a 7.5-per-cent discount rate (10 per cent prior), reflecting management’s strong execution ability and the retirement of production risk,” said Mr. Wolff. “We are increasing target price ... as the company nears commercial production. While the former Sigma operations will have short-term negative performance, we concentrate on the longer-term highly valued graphene production and value of the graphene production patents.”

<< Previous
Bullboard Posts
Next >>